Results 41 to 50 of about 156,095 (237)

Association of sildenafil use with age-related macular degeneration: a retrospective cohort study

BMJ Open Ophthalmology
Objective Despite significant advances in clinical care and understanding of the underlying pathophysiology, age-related macular degeneration (AMD)—a major cause of global blindness—lacks effective treatment to prevent the irreversible degeneration of ...
Nicola Jaime Adderley, Krishnarajah Nirantharakumar, Anuradhaa Subramanian, Alastair K Denniston, Wen Hwa Lee, Ji Eun Diana Han, Jesse Coker   +6 more
doaj   +1 more source

Metabolomics and Age-Related Macular Degeneration

Metabolites, 2018
Age-related macular degeneration (AMD) leads to irreversible visual loss, therefore, early intervention is desirable, but due to its multifactorial nature, diagnosis of early disease might be challenging.
Connor N. Brown, Brian D. Green, Richard B. Thompson, Anneke I. den Hollander, Imre Lengyel, on behalf of the EYE-RISK consortium   +5 more
doaj   +1 more source

Dual Sensory Impairment: The Correlation between Age Related Macular Degeneration and Sensorineural Hearing Loss

Medicina, 2022
The pathogeneses of age-related macular degeneration (AMD) and age-related hearing impairment are not yet fully understood. If AMD and age-related hearing impairment are correlated, the cause of both may be a result of a common vulnerability.
Marina Istrate, Mihai Hasbei-Popa, Daniela Adriana Iliescu, Ana Cristina Ghiță, Brigitha Vlaicu, Mihai Aurelian Ghiță   +5 more
doaj   +1 more source

Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article [PDF]

, 2017
Intravitreal antivascular endothelial growth factor drugs represent the current standard of care for neovascular age-related macular degeneration (nAMD).
Elena Gusson, Giacomo Panozzo, Giorgio Boschi, Giuseppe Scarpa, Nicola Zemella, null null, Sandro Saviano, Stefania Miotto, Stefano Piermarocchi   +8 more
core   +1 more source

Analysis of the Awareness and Access of Eye Healthcare in Underserved Populations

Vision
Introduction: Visual impairment impacts millions of people around the world, with the vast majority of problems being treatable. Disadvantaged communities are unable to utilize the same resources to treat these problems due to a lack of knowledge or ...
Karen Allison, Abdullah Virk, Asma Alamri, Deepkumar Patel   +3 more
doaj   +1 more source

The prevalence of age-related macular degeneration and osteoporosis in the older Polish population: Is there a link?

PLoS ONE, 2023
BackgroundAge-related macular degeneration is the primary cause of irreversible blindness in developed countries, whereas the global prevalence of osteoporosis-a major public health problem-is 19.7%.
Agnieszka Budnik, Marcin Palewski, Magdalena Michnowska-Kobylińska, Łukasz Lisowski, Magda Łapińska, Zofia Stachurska, Anna Szpakowicz, Jerzy Konstantynowicz, Karol Kamiński, Joanna Konopińska   +9 more
doaj   +1 more source

Acquired Vitelliform Macular Degeneration: Characteristics and Challenges of Managing Subretinal Fluid

Journal of Ophthalmic & Vision Research, 2021
Purpose: To highlight diagnostic challenges in patients with acquired vitelliform macular degeneration (AVMD) with subretinal fluid (SRF) and to examine the characteristics of image findings in patients with AVMD.
Joseph Juliano, Sagar Patel, Hossein Ameri   +2 more
doaj   +1 more source

Vascular Response to Sildenafil Citrate in Aging and Age-Related Macular Degeneration. [PDF]

, 2019
Age-related macular degeneration (AMD) - the leading cause of vision loss in the elderly - share many risks factors as atherosclerosis, which exhibits loss of vascular compliance resulting from aging and oxidative stress.
Agrawal, Rupesh, Cheung, Chui Ming Gemmy, Cunefare, David, Farsiu, Sina, Khandelwal, Neha, Migacz, Justin, Tran, Steven, Vuong, Vivian S, Yiu, Glenn   +8 more
core   +2 more sources

Age-related Macular Degeneration

International Ophthalmology Clinics, 1986
Age-related macular degeneration (AMD) is a major cause of visual loss. The atrophic form is more frequent but accounts for only 20% of severe visual loss. The neovascular form accounts for 80% of severe visual loss. The Macular Photocoagulation Study demonstrated that prompt argon laser photocoagulation can significantly reduce the risk of severe ...
openaire   +4 more sources

Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients

Journal of Current Ophthalmology
Purpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi, Golnoush Mahmoudinezhad, Nicola Valsecchi, Sharat Chandra Vupparaboina, Sandeep Chandra Bollepalli, Kiran Kumar Vupparaboina, Jose-Alain Sahel, Andrew W. Eller, Jay Chhablani   +8 more
doaj   +1 more source